Literature DB >> 2549766

Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas.

B Wowra1, H P Schmitt, V Sturm.   

Abstract

Late radiation necroses constitute a hazard in low dose rate interstitial irradiation for inoperable gliomas. An incidence of 40% (8/20 patients) was found after permanent implantation of Iodine-125 seeds. This finding may even underestimate the real frequency, because follow-up of unaffected patients was shorter than in patients with radiation necrosis. The necrotic reactions caused a transient mass effect, which lead to a significant deterioration of performance scores. Further manifestations of late delayed radiation damage were observed in two patients. The occurrence of radiation necrosis was correlated with total radiation dose, amount of implanted radioactivity, and with velocity of tumour shrinkage. A mechanism underlying the development of radiation necrosis is proposed: A rapid shrinkage of tumour after interstitial Iodine-125 implantation may cause a significant irradiation of surrounding brain tissue, which was initially lying outside the target volume. Since most patients affected by radiation necrosis were children or adolescents, the risk of radiation damage should be minimized. This could probably be achieved either by reduction of irradiation dose, or by using temporary implants of Iodine-125.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549766     DOI: 10.1007/BF01402316

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Diagnostic value of the stereotactic approach to focal lesions in the deep brain of children and adolescents.

Authors:  H P Schmitt; B Wowra; V Sturm
Journal:  Brain Dev       Date:  1988       Impact factor: 1.961

2.  Stereotactic computer tomography with a modified Riechert-Mundinger device as the basis for integrated stereotactic neuroradiological investigations.

Authors:  V Sturm; O Pastyr; W Schlegel; H Scharfenberg; H J Zabel; G Netzeband; S Schabbert; W Berberich
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

3.  Stereotactic interstitial brachytherapy for malignant brain tumors.

Authors:  P H Gutin; M Bernstein
Journal:  Prog Exp Tumor Res       Date:  1984

4.  Radiation necrosis.

Authors:  J R Fike; G E Sheline; C E Cann; R L Davis
Journal:  Prog Exp Tumor Res       Date:  1984

Review 5.  Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.

Authors:  P H Gutin; S A Leibel; W M Wara; A Choucair; V A Levin; T L Philips; P Silver; V Da Silva; M S Edwards; R L Davis
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

Review 6.  Stereotaxic interstitial irradiation of malignant brain tumors.

Authors:  P H Gutin; S A Leibel
Journal:  Neurol Clin       Date:  1985-11       Impact factor: 3.806

7.  125I interstitial brachytherapy for primary malignant brain tumors: technical aspects of treatment planning and implantation methods.

Authors:  P A Findlay; D C Wright; U Rosenow; F S Harrington; R W Miller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

8.  Radiation necrosis of the brain: time of onset and incidence related to total dose and fractionation of radiation.

Authors:  H Safdari; J M Fuentes; J B Dubois; M Alirezai; P Castan; B Vlahovitch
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

9.  The effect of 125I interstitial radiotherapy on blood-brain barrier function in normal canine brain.

Authors:  D R Groothuis; D C Wright; C B Ostertag
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

Review 10.  Interstitial irradiation of brain tumors: a review.

Authors:  M Bernstein; P H Gutin
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

View more
  7 in total

1.  Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.

Authors:  Pilar de la Puente; Nicole Fettig; Micah J Luderer; Abbey Jin; Shruti Shah; Barbara Muz; Vaishali Kapoor; Sreekrishna M Goddu; Noha Nabil Salama; Christina Tsien; Dinesh Thotala; Kooresh Shoghi; Buck Rogers; Abdel Kareem Azab
Journal:  J Pharm Sci       Date:  2017-11-21       Impact factor: 3.534

2.  Pineal region tumours treated with interstitial brachytherapy with low activity sources (192-iridium).

Authors:  K Matsumoto; H Higashi; S Tomita; T Ohmoto
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.

Authors:  A Gabriella Wernicke; Stefanie P Lazow; Shoshana Taube; Menachem Z Yondorf; Ilhami Kovanlikaya; Dattatreyudu Nori; Paul Christos; John A Boockvar; Susan Pannullo; Philip E Stieg; Theodore H Schwartz
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-08-01       Impact factor: 2.703

4.  Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas.

Authors:  M Matsutani; O Nakamura; T Nagashima; A Asai; T Fujimaki; H Tanaka; M Nakamura; K Ueki; Y Tanaka; T Matsuda
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases.

Authors:  M Scerrati; P Montemaggi; M Iacoangeli; R Roselli; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

6.  Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging.

Authors:  Christopher M McPherson; Ronald E Warnick
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

Review 7.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.